Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment
Clinical trial NCT07171723 · RECRUITING
Trial details
- NCT number
- NCT07171723
- Sponsor
- University Hospital, Gentofte, Copenhagen
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2025-12-14
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.